| Literature DB >> 34887710 |
Abstract
To discuss the application method and effect of COPD patients in deep learning in intelligent monitoring, two groups were used under a reasonable selection of antibiotics specifically including reasonable and effective oxygen administration, atomization, sputum discharge treatment, psychotherapy, and rehabilitation training and treatment. Results were indicated, and there were significant differences between the lung function evaluation index and the two groups. Its intelligent monitoring mode was 97.5% and 80.0%, while the red blood cell ratio, arterial oxygen partial pressure (PaO2), pulse blood oxygen saturation (SpO2), arterial carbon dioxide partial pressure (PaCO2), and symptom improvement were better than artificial and were statistically significant (P < 0.05). Therefore, the training of the anti-inspiratory muscle can effectively improve the lung function and dyspnea symptoms of COPD patients at the stable stage, thus greatly improving their respiratory function and ensuring the quality of life of patients, which is worthy of clinical application.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34887710 PMCID: PMC8629615 DOI: 10.1155/2021/5690442
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.161
Figure 1Kaplan–Meier curves of shedding probability of two offline methods.
Proportion of the clinical therapeutic effect between the two groups of patients with chronic obstructive pulmonary disease (%).
| Group | Example number | Clinical control | Effective | Invalid | Efficiency (%) |
|---|---|---|---|---|---|
| Intelligent group | 40 | 32 (80.0) | 7 (17.5) | 1 (2.5) | 97.5 |
| Artificial group | 40 | 23 (57.5) | 9 (22.5) | 8 (20.0) | 80.0 |
Compared with the manual, P < 0.05.
Comparison of indicators between the two groups of patients with COPD after treatment ().
| Group | Example number | SpO2 (%) | PaO2 (mmHg) | PaCO2 (mmHg) | Erythrocrit | Symptoms' improvement (d) |
|---|---|---|---|---|---|---|
| Intelligent group | 40 | 93.0 ± 2.5 | 82 ± 4 | 42.0 ± 2.5 | 0.47 ± 0.07 | 4.3 ± 3.2 |
| Artificial group | 40 | 88.0 ± 4.1 | 75 ± 3.2 | 46.0 ± 3.3 | 0.62 ± 0.07 | 8.6 ± 3.2 |
Compared with the manual period, P < 0.05.
Clinical therapeutic effect of chronic obstructive pulmonary disease.
| Clinical effects | Clinical control | Excellence | Effective | Invalid | Total effective |
|---|---|---|---|---|---|
| Example number ( | 9 | 14 | 5 | 2 | 28 |
| Scale (%) | 30.00 | 46.67 | 16.67 | 6.67 | 93.33 |
Blood gas analysis results of chronic obstructive pulmonary disease patients.
| Time | Example number | Partial pressure of carbon dioxide | Oxygen compression |
|---|---|---|---|
| Pretherapy | 30 | 52.00 ± 5.00 | 85.60 ± 2.60 |
| Posttreatment | 30 | 34.80 ± 2.20 | 92.00 ± 2.20 |